White Matter Lesions (Leukoaraiosis): A Major Cause of Falls

Journal of the American Medical Directors Association

Volumn 16, Issue 6, 2015, Pages 441-443

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE DEFECT; DEPRESSION; DIABETES MELLITUS; EDITORIAL; EXECUTIVE FUNCTION; HUMAN; HYPERTENSION; LEUKOARAIOSIS; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER LESION; AGE; CARDIOVASCULAR DISEASE; COMPLICATION; FALLING; PATHOLOGY; RISK FACTOR; WHITE MATTER;

ACCIDENTAL FALLS; AGE FACTORS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; RISK FACTORS; WHITE MATTER;

EID: 84929963170     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.03.023     Document Type: Editorial

References (101)

1. Binswanger O. Die Abrenzung der allgemeinen progressiven Paralyse. Berl Klin Wochenschr 1894, 31:1180-1186. [German].
2. Hachinski V.C., Potter P., Merskey H. Leuko-araiosis: An ancient term for a new problem. Can J Neurol Sci 1986, 13:533-534.
3. Hachinski V.C., Potter P., Merskey H. Leuko-araiosis. Arch Neurol 1987, 44:21-23.
4. Awad I.A., Spetzler R.F., Hodak J.A., et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986, 17:1084-1089.
5. Awad I.A., Johnson P.C., Spetzler R.F., Hodak J.A. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke 1986, 17:1090-1097.
6. DeCarli C. Clinically asymptomatic vascular brain injury: A potent cause of cognitive impairment amongst older individuals. JAlzheimers Dis 2013, 33:S417-S426.
7. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: A review. Stroke 1997, 28:652-659.
8. Fazekas F., Kleinert R., Offenbacher H., et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993, 43:1683-1689.
9. Al-Mashhadi S., Simpson J.E., Heath P.R., et al. Oxidative glial cell damage associated with white matter lesions in the aging human brain. Brain Pathol 2014 Oct 14, Medical Research Council Cognitive Function and Ageing Study, [Epub ahead of print].
10. Michaud M., Balardy L., Moulis G., et al. Proinflammatory cytokines, aging, and age-related diseases. JAm Med Dir Assoc 2013, 14:877-882.
11. Morley J.E. New horizons in the management of Alzheimer disease. JAm Med Dir Assoc 2015, 16:1-5.
12. Morley J.E., Farr S.A., Kumar V.B., Armbrecht H.J. The SAMP8 mouse: A model to develop therapeutic interventions for Alzheimer's disease. Curr Pharm Des 2012, 18:1123-1130.
13. Morley J.E. Mild cognitive impairment-A treatable condition. JAm Med Dir Assoc 2014, 15:1-5.
14. Cruz-Oliver D.M., Malmstrom T.K., Roegner M., et al. Cognitive deficit reversal as shown by changes in the Veterans Affairs Saint Louis University Mental Status (SLUMS) examination scores 7.5 years later. JAm Med Dir Assoc 2014, 15:687.e5-687.e10.
15. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010, 9:689-701.
16. Murray M.E., Senjem M.L., Petersen P.C., et al. Functional impact of white matter hyperintensities in cognitively normal elderly. Arch Neurol 2010, 67:1379-1385.
17. Schmitt E.M., Marcantonio E.R., Alsop D.C., et al. Novel risk markers and long-term outcomes of delirium: The successful aging after elective surgery (SAGES) study design and methods. JAm Med Dir Assoc 2012, 13:818.e1-818.e10.
18. Longstreth W.T., Manolio T.A., Arnold A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996, 27:1274-1282.
19. Brickman A.M., Seidlecki K.L., Muraskin J., et al. White matter hyperintensities and cognition: Testing the reserve hypothesis. Neurobiol Aging 2011, 32:1588-1598.
20. Van Dyk E.J., Prins N.D., Vrooman H.A., et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 2008, 39:2712-2719.
21. Berger K., Roesler A., Kretzschmar K. The association between white matter lesions, stroke and activities of daily living-The MEMO study on the KORA platform Augsburg. Gesundheitswesen 2005, 67:S172-S175.
22. Moulis F., Moulis G., Balardy L., et al. Exposure to atropinic drugs and frailty status. JAm Med Dir Assoc 2015, 16:253-257.
23. Landi F., Dell'Aquila G., Collamati A., et al. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. JAm Med Dir Assoc 2014, 15:825-829.
24. Morley J.E. Anticholinergic medications and cognition. JAm Med Dir Assoc 2011, 12:543-543.e1.
25. Lowry E., Woodman R.J., Soiza R.L., Mangoni A.A. Associations between the anticholinergic risk scale score and physical function: Potential implications for adverse outcomes in older hospitalized patients. JAm Med Dir Assoc 2011, 12:565-572.
26. Sanford A., Morley J.E. Are the new guidelines for cholesterol and hypertension age friendly?. JAm Med Dir Assoc 2014, 15:373-375.
27. van der Wardt V., Logan P., Conroy S., et al. Antihypertensive treatment in people with dementia. JAm Med Dir Assoc 2014, 15:620-629.
28. Aronow W.S. Treatment of hypertension in the elderly. JAm Med Dir Assoc 2013, 14:847.
29. Welsh T., Gladman J., Gordon A.L. The treatment of hypertension in care home residents: A systematic review of observational studies. JAm Med Dir Assoc 2014, 15:8-16.
30. Jacobs J.M., Stessman J., Ein-Mor E., Bursztyn M. Hypertension and 5-year mortality among 85-year-olds: The Jerusalem Longitudinal Study. JAm Med Dir Assoc 2012, 13:759.e1-759.e6.
31. Morley J.E. Treatment of hypertension in older persons: What is the evidence?. Drugs Aging 2014, 31:331-337.
32. Peng J., Lue F., Wang Z., et al. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study. JAm Med Dir Assoc 2014, 15:904-910.
33. Nazir A., Mueller C., Perkins A., Arling G. Falls and nursing home residents with cognitive impairment: New insights into quality measures and interventions. JAm Med Dir Assoc 2012, 13:819.e1-819.e6.
34. Kabeshova A., Launay C.P., Gromov V.A., et al. Artificial neural network and falls in community-dwellers: A new approach to identify the risk of recurrent falling?. JAm Med Dir Assoc 2014, 16:277-281.
35. Ayoubi F., Launay C.P., Annweiler C., Beauchet O. Fear of falling and gait variability in older adults: A systematic review and meta-analysis. JAm Med Dir Assoc 2015, 16:14-19.
36. Büchele G., Becker C., Cameron I.D., et al. Predictors of serious consequences of falls in residential aged care: Analysis of more than 70,000 falls from residents of Bavarian nursing homes. JAm Med Dir Assoc 2014, 15:559-563.
37. Engelhart D., Pasma J.H., Schouten A.C., et al. Impaired standing balance in elderly: A new engineering method helps to unravel causes and effects. JAm Med Dir Assoc 2014, 15:227.e1-227.e6.
38. Morley J.E., Rolland Y., Tolson D., Vellas B. Increasing awareness of the factors producing falls: The mini-falls assessment. JAm Med Dir Assoc 2012, 13:87-90.
39. Ogama N., Sakurai T., Shimizu A., Toba K. Regional white matter lesions predict falls in patients with amnestic mild cognitive impairment and Alzheimer's disease. JAm Med Dir Assoc 2014, 15:36-41.
40. Srikanth V., Beare R., Blizzard L., et al. Cerebral white matter lesions, gait, and the risk of incident falls: A prospective population-based study. Stroke 2009, 40:175-180.
41. Baezner H., Blahak C., Poggesi A., et al. Association of gait and balance disorders with age-related white matter changes: The LADIS study. Psychol Med 2010, 40:603-610.
42. Ampadu J., Morley J.E. Heart failure and cognitive dysfunction. Int J Cardiol 2015, 178:12-23.
43. Hui D.S., Morley J.E., Mikolajczak P.C., Lee R. Atrial fibrillation: A major risk factor for cognitive decline. Am Heart J 2015, 169:448-456.
44. Almeida O.P., Hankey G.J., Yeap B.B., et al. Depression, frailty, and all-cause mortality: A cohort study of men older than 75 years. JAm Med Dir Assoc 2014, 16:296-300.
45. Thakur M., Blazer D.G. Depression in long-term care. JAm Med Dir Assoc 2008, 9:82-87.
46. Makizako H., Shimada H., Doi T., et al. Physical frailty predicts incident depressive symptoms in elderly people: Prospective findings from the Obu study of health promotion for the elderly. JAm Med Dir Assoc 2015, 16:194-199.
47. Kurita N., Horie S., Yamazaki S., et al. Low testosterone levels, depressive symptoms, and falls in older men: A cross-sectional study. JAm Med Dir Assoc 2014, 15:30-35.
48. Rottenberg Y., Jacobs J.M., Stessman J. Depression and health service utilization from age 70 to 85: The Jerusalem Longitudinal Study. JAm Med Dir Assoc 2013, 14:711.e1-711.e6.
49. Teodorczuk A., Firbank M.J., Pantoni L., et al. relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med 2010, 40:603-610.
50. Wang L., Leonards C.O., Sterzer P., Ebinger M. White matter lesions and depression: A systematic review and meta-analysis. JPsychiatr Res 2014, 56:56-64.
51. Chen M.H., Li C.T., Tsai C.F., et al. Risk of subsequent dementia among patients with bipolar disorder or major depression: A nationwide longitudinal study in Taiwan. JAm Med Dir Assoc 2015, 16:504-508.
52. Hubbard R.E., Lang I. Avoiding depression, dementia, and frailty: Do you feel lucky?. JAm Med Dir Assoc 2015, 16:270-271.
53. Feng L., Nyunt M.S., Feng L., et al. Frailty predicts new and persistent depressive symptoms among community-dwelling older adults: Findings from Singapore longitudinal aging study. JAm Med Dir Assoc 2014, 15:76.e7-76.e12.
54. Morley J.E. Frailty, falls, and fractures. JAm Med Dir Assoc 2013, 14:149-151.
55. Rosenthal M.J., Fajardo M., Gilmore S., et al. Hospitalization and mortality of diabetes in older adults. A 3-year prospective study. Diabetes Care 1998, 21:231-235.
56. Bouillon K., Kivimäki M., Hamer M., et al. Diabetes risk factors, diabetes risk algorithms, and the prediction of future frailty: The Whitehall II prospective cohort study. JAm Med Dir Assoc 2013, 14:851.e1-851.e6.
57. Maldjian J.A., Whitlow C.T., Saha B.N., et al. Automated white matter total lesion volume segmentation in diabetes. AJNR Am J Neuroradiol 2013, 34:2265-2270.
58. Verdelho A., Madureira S., Moleiro C., et al. White matter changes and diabetes predict cognitive decline in the elderly: The LADIS study. Neurology 2010, 75:160-167.
59. Morley J.E., Malmstrom T.K., Rodriguez-Mañas L., Sinclair A.J. Frailty, sarcopenia and diabetes. JAm Med Dir Assoc 2014, 15:853-859.
60. Sinclair A., Morley J.E., Rodriguez-Mañas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. JAm Med Dir Assoc 2012, 13:497-502.
61. Formiga F., Ferrer A., Padros G., et al. Diabetes mellitus as a risk factor for functional and cognitive decline in very old people: The Octabaix study. JAm Med Dir Assoc 2014, 15:924-928.
62. Enzinger C., Fazekas F., Ropele S., et al. Progression of cerebral white matter lesions-Clinical and radiological considerations. JNeurol Sci 2007, 257:5-10.
63. Morley J.E., Vellas B., van Kan G.A., et al. Frailty consensus: A call to action. JAm Med Dir Assoc 2013, 14:392-397.
64. Mitnitski A., Fallah N., Rockwood M.R., Rockwood K. Transitions in cognitive status in relation to frailty in older adults: A comparison of three frailty measures. JNutr Health Aging 2011, 15:863-867.
65. Von Haehling S., Anker S.D., Doehner W., et al. Frailty and heart disease. Int J Cardiol 2013, 168:1745-1747.
66. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
67. Morley J.E., Malmstrom T.K., Miller D.K. Asimple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. JNutr Health Aging 2012, 16:601-608.
68. Morley J.E. Frailty screening comes of age. JNutr Health Aging 2014, 18:453-454.
69. Morley J.E., von Haehling S., Anker S.D., Vellas B. From sarcopenia to frailty: A road less traveled. JCachexia Sarcopenia Muscle 2014, 5:5-8.
70. Nishiguchi S., Yamada M., Fukutani N., et al. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults. JAm Med Dir Assoc 2015, 16:120-124.
71. Shimada H., Makizako H., Doi T., et al. Combined prevalence of frailty and mild cognitive impairment in a population of elderly Japanese people. JAm Med Dir Assoc 2013, 14:518-521.
72. Malmstrom T.K., Morley J.E. The frail brain. JAm Med Dir Assoc 2013, 14:453-455.
73. Halil M., Cemal Kizilarslanoglu M., Emin Kuyumcu M., et al. Cognitive aspects of frailty: Mechanisms behind the link between frailty and cognitive impairment. JNutr Health Aging 2015, 19:276-283.
74. Forti P., Maioli F., Zagni E., et al. The physical phenotype of frailty for risk stratification of older medical inpatients. JNutr Health Aging 2014, 18:912-918.
75. Dartiques J.F., Amieva H. Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. JNutr Health Aging 2014, 18:95.
76. Kelaiditi E., Cesari M., Canevelli M., et al. Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. JNutr Health Aging 2013, 17:726-734.
77. Cano C., Samper-Ternent R., Al Snih S., et al. Frailty and cognitive impairment as predictors of mortality in older Mexican Americans. JNutr Health Aging 2012, 16:142-147.
78. Yassuda M.S., Lopes A., Cachioni M., et al. Frailty criteria and cognitive performance are related: Data from the FIBRA study in Ermelino Matarazzo, São Paulo, Brazil. JNutr Health Aging 2012, 16:55-61.
79. Canevelli M., Cesari M. Cognitive frailty: What is still missing?. JNutr Health Aging 2015, 19:273-275.
80. Collard R.M., Comijs H.C., Naarding P., et al. Frailty as a predictor of the incidence and course of depressed mood. JAm Med Dir Assoc 2015, 16:509-514.
81. Morley J.E. Exercise: The ultimate medicine. JAm Med Dir Assoc 2015, 16:351-353.
82. Churchward-Venne T.A., Tieland M., Verdijk L.B., et al. There are no nonresponders to resistance-type exercise training in older men and women. JAm Med Dir Assoc 2015, 16:400-411.
83. Day L., Hill K.D., Stathakis V.Z., et al. Impact of Tai-Chi on falls among preclinically disabled older people. A randomized controlled trial. JAm Med Dir Assoc 2015, 16:420-426.
84. Edgren J., Salpakoski A., Sihvonen S.E., et al. Effects of a home-based physical rehabilitation program on physical disability after hip fracture: A randomized controlled trial. JAm Med Dir Assoc 2015, 16:350.e1-350.e7.
85. Chan W.C., Yeung J.W., Wong C.S., et al. Efficacy of physical exercise in preventing falls in older adults with cognitive impairment: A systematic review and meta-analysis. JAm Med Dir Assoc 2015, 16:149-154.
86. Silva R.B., Eslick G.D., Duque G. Exercise for falls and fracture prevention in long term care facilities: A systematic review and meta-analysis. JAm Med Dir Assoc 2013, 14:685-689.e2.
87. Paddon-Jones D. Perspective: Exercise and protein supplementation in frail elders. JAm Med Dir Assoc 2013, 14:73-74.
88. Lam L.C., Chau R.C., Wong B.M., et al. A1-year randomized controlled trial comparing mind body exercise (Tai Chi) with stretching and toning exercise on cognitive function in older Chinese adults at risk of cognitive decline. JAm Med Dir Assoc 2012, 13:568.e15-568.e20.
89. Yamada M., Arai H., Sonoda T., Aoyama T. Community-based exercise program is cost-effective by preventing care and disability in Japanese frail older adults. JAm Med Dir Assoc 2012, 13:507-511.
90. Singh N.A., Quine S., Clemson L.M., et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. JAm Med Dir Assoc 2012, 13:24-30.
91. Colberg S.R., Somma C.T., Sechrist S.R. Physical activity participation may offset some of the negative impact of diabetes on cognitive function. JAm Med Dir Assoc 2008, 9:434-438.
92. Rolland Y., Abellan van Kan G., Vellas B. Physical activity and Alzheimer's disease: From prevention to therapeutic perspectives. JAm Med Dir Assoc 2008, 9:390-405.
93. Morley J.E. The magic of exercise. JAm Med Dir Assoc 2008, 9:375-377.
94. Fiatarone Singh M.A., Gates N., Saigal N., et al. The Study of Mental And Resistance Training (SMART) study - resistance training and/or cognitive training in mild cognitive impairment: A randomized, double-blind, double-sham controlled trial. JAm Med Dir Assoc 2014, 15:873-880.
95. Vankova H., Holmerova I., Machacova K., et al. The effect of dance on depressive symptoms in nursing home residents. JAm Med Dir Assoc 2014, 15:582-587.
96. Loraine J., Taylor S., McAllister M. Cognitive and physical stimulation therapy. JAm Med Dir Assoc 2014, 15:140-141.
97. León-Muñoz L.M., Guallar-Castillón P., López-García E., Rodriguez-Artalejo F. Mediterranean diet and risk of frailty in community-dwelling older adults. JAm Med Dir Assoc 2014, 15:899-903.
98. Feart G., Samieri C., Barberger-Gateau P. Mediterranean diet and cognitive health: An update of available knowledge. Curr Opin Clin Nutr Metab Care 2015, 18:51-62.
99. Morley J.E. Cognition and nutrition. Curr Opin Clin Nutr Metab Care 2014, 17:1-4.
100. Shah R. The role of nutrition and diet in Alzheimer disease: A systematic review. JAm Med Dir Assoc 2013, 14:398-402.
101. Nardone R., Tezzon F., Höller Y., et al. Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease. Acta Neurol Scand 2014, 129:351-366.